Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin

Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin

US Patent 8414921 · Granted Apr 9, 2013

Estimated economic value: $69,688,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Extended local release of anti-CSFR1 antibodies2025
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
Stable protein solution formulation containing high concentration of an anti-VEG2024
Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cel2023
Extended local release of anti-CSFR1 antibodies2022
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2022
Stable protein solution formulation containing high concentration of an anti-VEG2020
Controlled release formulations of levodopa and uses thereof2018
Controlled release formulations of levodopa and uses thereof2017
High concentration olopatadine ophthalmic composition2017
Finafloxacin suspension compositions2016
Controlled release formulations of levodopa and uses thereof2016